Drug resistance in certain prostate cancers can be reversed by stopping tumours from “hijacking” a subset of white blood cells in order to help fuel their growth. This is the conclusion of an international team of researchers who have demonstrated in an early clinical trial that targeting the messages cancer cells use to pull in these white blood cells can […]

When a friend messes up—forgets a birthday, blows off plans or doesn’t pull their weight—it’s normal for you to feel angry and for them to feel guilty. And if they mess up again, it’s tempting to assume their guilt will increase as your temperature rises. But that’s not how it works. In a new study published in Emotion, researchers at […]

How doing ARM exercises could ease KNEE pain READ MORE: I’m a physiotherapist: What’s behind knee pain and how to treat it Can you boost the health of one part of the body by exercising a different part of it? As unlikely as it sounds, the idea is gaining ground among scientists looking for new ways to manage the effects […]

What IS the truth about the ‘manopause’? As Robbie Williams blames declining testosterone for killing his libido and triggering insomnia, doctors say disputed phenomenon IS real but argue term is hugely ‘misleading’ Drs say andropause symptoms can often be caused by other health conditions READ MORE: Is mobile phone use behind a lowering of men’s sperm counts? Is thinning hair and […]

National Pit Bull Awareness Day is just around the corner—October 28 to be exact—and we’re so excited for one of our favorite days of the year that we’re kicking off our celebrations early. This year, we wanted to give a shout-out to some amazing pittie parents who, simply by loving their pit bull, are helping to put an end to the […]

The US Food and Drug Administration (FDA) has approved infliximab-dyyb (Zymfentra, Celltrion USA) for maintenance therapy in adults with moderately to severely active ulcerative colitis (UC) and Crohn’s disease (CD) after treatment with an intravenous (IV) infliximab product. Infliximab-dyyb is a subcutaneous (SC) formulation of Celltrion’s infliximab biosimilar. The FDA approval provides an alternative administration option for delivering the drug, […]

A new study has revealed that Metixene, an antiparkinsonian drug, has shown remarkable potential as a novel treatment for metastatic breast cancer and brain metastases, providing hope for patients facing this devastating disease. The study was conducted by a team of researchers led by Dr. Jawad Fares at Northwestern University and was published in the Journal of Clinical Investigation. Metastatic […]

Source: Read Full Article

Most common psychiatric disorder in children Exploring a possible mechanism Source: Read Full Article

Findings from a multi-center, international clinical trial reported by a Cleveland Clinic physician show that semaglutide reduced cardiovascular events by 20% in adults with overweight or obesity and established cardiovascular disease who do not have diabetes. Semaglutide is primarily prescribed for adults with type 2 diabetes but is also approved for chronic weight management in adults with obesity or overweight […]